Financial burden of prescription drugs is dropping: Costs remain a challenge for many

February 8, 2012

The financial burden Americans face paying out-of-pocket costs for prescription drugs has declined, although prescription costs remain a significant challenge for people with lower incomes and those with public insurance, according to a new RAND Corporation study.

Despite the improvement, more than 8 million nonelderly Americans lived in families with high drug-cost burden in 2008 and one in four devoted more than half of their total out-of-pocket medical spending to prescription drugs, according to findings published in the February edition of the journal Affairs.

"Our findings are evidence of the success of strategies already in place to help lower the cost of medications for consumers, even during a period when medication use was increasing," said Dr. Walid Gellad, the study's lead author and a researcher at RAND, a nonprofit research organization. "But the burden of drug costs remains high for many Americans, which is an important issue for policymakers to consider as extends to more people."

The primary reason for the drop in consumers' prescription drug costs is an increased use of , according to researchers. Over the last decade, changes in encouraged consumers to use generics and many high-demand medications became available in generic form.

While prescription drug spending accounts for 10 percent of all health care spending in the United States, out-of-pocket costs for make up a much larger percentage of individual health spending, particularly among low-income people with public insurance and those with such as diabetes.

"Because medications are a large part of the household health budget, they are obvious targets for households when they need to decrease their health expenses, which can have adverse consequences down the road," said Gellad, who also is an assistant professor of medicine and health policy at the University of Pittsburgh, a staff physician at the Pittsburgh VA Medical Center, and a researcher with the VA Center for Health Equity Research and Promotion.

The researchers examined information about individual drug spending from 1999 to 2008 among people tracked by the federal Medical Expenditure Panel Survey.

The study found that the percentage of people with high for prescription drugs increased from 1999 to 2003, decreased from 2003 to 2007, and had a slight increase in 2008. The study defined "high financial burden" as living in a family that spends more than 10 percent of its income on out-of-pocket expenses for prescription drugs.

The study found that in 1999 about 3 percent of nonelderly Americans (7 million people) lived in families that spent more than 10 percent of their income on and nearly 27 percent of nonelderly Americans (64.5 million) belonged to families where out-of-pocket drug costs accounted for more than half of all out-of-pocket health care costs.

By 2003, out-of-pocket drug costs had climbed higher. More than 4 percent of nonelderly Americans (10.8 million) had high drug-cost burden and 33.6 percent (85.2 million) lived in families where drug costs accounted for more than half of all out-of-pocket health care expenses. But by 2008, these numbers had decreased to 3.1 percent for families with a high drug-cost burden (8.3 million) and 25.4 percent for families with drug costs accounting for more than half of all out-of-pocket costs (67.1 million).

The drug cost burden differed substantially based on family income and types of insurance. In 2008, the percentage of people living in families with a high drug cost burden was 7.5 percent among those with , 4.5 percent among those with privately purchased individual health plans and only 1.2 percent for those with group or employer-related insurance.

"These differences are important as the Affordable Care Act will expand coverage to 24 million people through new health insurance exchanges that build on the nongroup insurance market," Gellad said."There is the expectation that future nongroup policies will provide better, more-generous drug coverage than existing policies, but the level of generosity remains to be seen."

The study also found that people with chronic health conditions were more likely to face a high financial burden because of drug costs. In 2008, more than one in eight people with diabetes faced a high financial burden because of drug costs and a majority of people with the illness lived in families where drug costs accounted for more than half of all out-of-pocket . Similar trends were seen for patients with high blood pressure and mental disorders.

Explore further: Reducing drug funding to Medicare patients will lead many to stop taking their medications

Related Stories

Recommended for you

Can nicotine protect the aging brain?

September 20, 2016

Everyone knows that tobacco products are bad for your health, and even the new e-cigarettes may have harmful toxins. However, according to research at Texas A&M, it turns out the nicotine itself—when given independently ...

Science can shape healthy city planning

September 23, 2016

Previous studies have shown a correlation between the design of cities and growing epidemics of injuries and non-communicable diseases such as heart disease, diabetes and cancer. A three-part series published in The Lancet ...

50-country comparison of child and youth fitness levels

September 21, 2016

An international research team co-led from the Children's Hospital of Eastern Ontario (CHEO) and the University of North Dakota studied the aerobic fitness levels of children and youth across 50 countries. The results are ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.